Post by PharmaShots

16,877 followers

šŸ’­"šƒšžššš„š¬ ššš«šžš§'š­ š¦ššššž šØšÆšžš«š§š¢š š”š­." One of the most interesting insights from our recent conversation with Jared Kelly, CEO & Director of Oncolytics Biotech Inc. was that biotech acquisitions are rarely the result of a single negotiation. Instead, they are built through years of relationship-building, trust, strategic partnerships, and consistent execution. While some deals may move faster than others, successful acquisitions often begin long before formal discussions take place. As Jared explains, creating value isn't just about strong data; it's about establishing credibility and fostering long-term partnerships that make a deal beneficial for everyone involved. šŸŽ„ Watch this short clip to hear his perspective on what really drives successful biotech acquisitions. šŸŽ§ Watch & Listen on PharmaShots Now: ā–¶ļø YouTube: https://lnkd.in/gKXt5ESC šŸŽ™ļø Spotify: https://lnkd.in/gUmtCU3Q šŸ“° Substack: https://lnkd.in/gdcJuBi6 #Biotech #Acquisition #MergersAndAcquisitions #Pharma #Biopharma #Leadership #BusinessDevelopment #HealthcareInnovation #PharmaShots #MandA

Post content

Video Content